Aurora Cannabis ACB
NASDAQ ACB
$3.79 -0.13 (-3.20%)
At close: Aug 20, 2026 · 11:59 AM UTC

Aurora Cannabis (ACB) Liabilities from Discontinued Operations (2022 - 2024)

Aurora Cannabis (ACB) posted quarterly Liabilities from Discontinued Operations of 939041.42 for Q3 2024, up 6.5% quarter-over-quarter from 881755.5 in Q2 2024.

Aurora Cannabis (ACB) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends

Aurora Cannabis (ACB) has reported Liabilities from Discontinued Operations for 2 consecutive years, with 939041.42 the latest figure, recorded in Q3 2024.

  • In Q3 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 939041.42; the TTM figure through Sep 2024 stood at 939041.42 (changed N/A YoY), while the FY2022 annual figure was 4732706.24, changed N/A from the prior year.
  • Liabilities from Discontinued Operations grew to 939041.42 in Q3 2024 per ACB's latest filing, from 881755.5 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 4696631.83 in Q2 2022 and bottomed at 881755.5 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.07 Bn 43.10 Bn -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn -
10 Aurora Cannabis 233.15 Mn 160.83 Mn 25.75 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 939,041.42
Sep 30, 2024 939,041.42
Jun 30, 2024 881,755.50
Jun 30, 2024 881,755.50
Dec 31, 2022 1.47 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 4.60 Mn
Sep 30, 2022 4.60 Mn
Jun 30, 2022 4.70 Mn
Jun 30, 2022 4.70 Mn
Mar 31, 2022 3.14 Mn
Mar 31, 2022 3.14 Mn